summaryrefslogtreecommitdiffstats
diff options
context:
space:
mode:
authorDavid A. Madore <david+git@madore.org>2020-09-08 17:01:56 +0200
committerDavid A. Madore <david+git@madore.org>2020-09-08 17:01:56 +0200
commit1206995a67b49a628c822145d73d3d5119ed4498 (patch)
treeb38b988863f78a2bc433abbc27d42d8fc5b9d75c
parent08bc2388e48ff200fcf82c406c7b7a6bd1f830ca (diff)
downloadcovid19-1206995a67b49a628c822145d73d3d5119ed4498.tar.gz
covid19-1206995a67b49a628c822145d73d3d5119ed4498.tar.bz2
covid19-1206995a67b49a628c822145d73d3d5119ed4498.zip
Link to BMJ editorial re underestimating seroprevalence.
-rw-r--r--covid19-links.md7
1 files changed, 7 insertions, 0 deletions
diff --git a/covid19-links.md b/covid19-links.md
index 99eaec6..95c6677 100644
--- a/covid19-links.md
+++ b/covid19-links.md
@@ -102,6 +102,13 @@
## Topical or time-specific links: ##
+* [Are we underestimating seroprevalence of
+ SARS-CoV-2?](https://www.bmj.com/content/370/bmj.m3364) (*British
+ Medical Journal* editorial, 2020-09-03). Emphasizes the fact that
+ SARS-CoV-2 seroprevalence studies show considerable variation and
+ may underestimate true seroprevalence; and encourages testing for
+ IgA antibodies.
+
* [Humoral Immune Response to SARS-CoV-2 in
Iceland](https://www.nejm.org/doi/full/10.1056/NEJMoa2026116) (NEJM,
2020-09-01). Conclusion: “Our results indicate that antiviral